MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035
(NASDAQ: MTVA) Delayed: 1.48 +0.03 (2.07%)
Previous Close $1.45    52 Week High $ 
Open $1.46    52 Week Low $ 
Day High $1.56    P/E N/A 
Day Low $1.38    EPS $ 
Volume 153,910